Natus Medical to Hold 2022 First Quarter Financial Results Conference Call on May 6th

Rhea-AI Summary

Natus Medical Incorporated (NASDAQ: NTUS) announced it will release its 2022 Q1 financial results on May 5, 2022, after market close. A conference call will follow on May 6 at 8:00 a.m. ET to discuss the results. Interested listeners can join via phone or the Internet. Natus, a leader in medical solutions for central nervous and sensory system disorders, operates in over 100 countries, providing advanced diagnostic and treatment solutions aimed at improving patient outcomes.

Positive

• Natus continues to lead in neurodiagnostics and pediatric retinal imaging.
• The company operates in over 100 countries, showcasing its global presence.

Negative

• None.

PLEASANTON, Calif., April 01, 2022 (GLOBE NEWSWIRE) -- Natus Medical Incorporated (NASDAQ: NTUS), (the “Company” or “Natus”), a leading provider of medical device solutions focused on the diagnosis and treatment of central nervous and sensory system disorders for patients of all ages, announced today that the Company will release its 2022 first quarter financial results after the close of the market on Thursday, May 5^th. Natus management will host a conference call on Friday, May 6^th at 8:00 a.m. Eastern Time (5:00 a.m. Pacific Time) to discuss those results and to answer questions.

Individuals interested in listening to the conference call may do so by dialing 1-844-634-1441 for domestic callers, or 1-508-637-5658 for international callers, and entering reservation code 6843838. A telephone replay will be available for 48 hours following the conclusion of the call by dialing 1-855-859-2056 for domestic callers, or 1-404-537-3406 for international callers, and entering reservation code 6843838.

The conference call also will be available real-time via the Internet at http://investor.natus.com and a recording of the call will be available on the Company's Web site for 90 days following the completion of the call.

About Natus Medical Incorporated

Natus delivers innovative and trusted solutions to screen, diagnose, and treat disorders affecting the brain, neural pathways, and eight sensory nervous systems to advance the standard of care and improve patient outcomes and quality of life. The Company offers hardware, advanced software and algorithms, and consumables that provide stimulus, acquire and monitor physiological signals, and capture the body’s response. With sales in over 100 countries, Natus is the clear worldwide leader in neurodiagnostics, pediatric retinal imaging, and infant hearing screening, as well as a leading company in hearing assessment, hearing instrument fitting, balance, and intracranial pressure monitoring.

Additional information about Natus Medical can be found at www.natus.com. 

COMPANY CONTACT:
Natus Medical Incorporated
Drew Davies
Executive Vice President and Chief Financial Officer
(925) 223-6700
InvestorRelations@Natus.com 

FAQ

When will Natus Medical release its Q1 2022 financial results?

Natus Medical will release its Q1 2022 financial results on May 5, 2022, after market close.

What time is the Natus Medical conference call for Q1 2022 results?

The conference call for Q1 2022 results will take place on May 6, 2022, at 8:00 a.m. Eastern Time.

How can I listen to the Natus Medical conference call?

You can listen by dialing 1-844-634-1441 for domestic calls or 1-508-637-5658 for international calls, using reservation code 6843838.

What are Natus Medical's key areas of operation?

Natus Medical focuses on solutions for central nervous and sensory system disorders, including neurodiagnostics and pediatric hearing screening.